CA2852874A1 - Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof - Google Patents

Info

Publication number

CA2852874A1

CA2852874A1 CA2852874A CA2852874A CA2852874A1 CA 2852874 A1 CA2852874 A1 CA 2852874A1 CA 2852874 A CA2852874 A CA 2852874A CA 2852874 A CA2852874 A CA 2852874A CA 2852874 A1 CA2852874 A1 CA 2852874A1

Authority

CA

Canada

Prior art keywords

amino acid

seq

acid sequence

polypeptide

sequence

Prior art date

2011-10-19

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 108020001621 Natriuretic Peptide Proteins 0.000 title claims abstract description 176
• 102000004571 Natriuretic peptide Human genes 0.000 title claims abstract description 176
• 239000000692 natriuretic peptide Substances 0.000 title claims abstract description 148
• 238000000034 method Methods 0.000 title claims abstract description 143
• 239000000203 mixture Substances 0.000 title claims abstract description 78
• 102000002260 Alkaline Phosphatase Human genes 0.000 title claims abstract description 45
• 108020004774 Alkaline Phosphatase Proteins 0.000 title claims abstract description 45
• 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 376
• 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 354
• 229920001184 polypeptide Polymers 0.000 claims abstract description 350
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 96
• 210000000988 bone and bone Anatomy 0.000 claims abstract description 75
• 208000022145 neurocutaneous syndrome Diseases 0.000 claims abstract description 36
• 102100027842 Fibroblast growth factor receptor 3 Human genes 0.000 claims abstract description 33
• 101710182396 Fibroblast growth factor receptor 3 Proteins 0.000 claims abstract description 33
• 208000020084 Bone disease Diseases 0.000 claims abstract description 28
• 208000015100 cartilage disease Diseases 0.000 claims abstract description 28
• 208000003019 Neurofibromatosis 1 Diseases 0.000 claims abstract description 18
• 108060003951 Immunoglobulin Proteins 0.000 claims abstract description 16
• 102000018358 immunoglobulin Human genes 0.000 claims abstract description 16
• 208000029578 Muscle disease Diseases 0.000 claims abstract description 15
• 208000021642 Muscular disease Diseases 0.000 claims abstract description 15
• 210000002464 muscle smooth vascular Anatomy 0.000 claims abstract description 15
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 444
• 125000000539 amino acid group Chemical group 0.000 claims description 393
• 229940024606 amino acid Drugs 0.000 claims description 246
• 235000001014 amino acid Nutrition 0.000 claims description 232
• 150000001413 amino acids Chemical class 0.000 claims description 189
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 86
• 108010038664 atrial natriuretic factor receptor B Proteins 0.000 claims description 71
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 61
• 241000282414 Homo sapiens Species 0.000 claims description 49
• 210000004899 c-terminal region Anatomy 0.000 claims description 48
• 201000010099 disease Diseases 0.000 claims description 43
• 239000008194 pharmaceutical composition Substances 0.000 claims description 43
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 39
• 239000012634 fragment Substances 0.000 claims description 37
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 33
• 229910052720 vanadium Inorganic materials 0.000 claims description 33
• 238000003776 cleavage reaction Methods 0.000 claims description 32
• 230000007017 scission Effects 0.000 claims description 32
• 102000005600 Cathepsins Human genes 0.000 claims description 24
• 108010084457 Cathepsins Proteins 0.000 claims description 24
• 239000000556 agonist Substances 0.000 claims description 24
• 235000003704 aspartic acid Nutrition 0.000 claims description 24
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 24
• 235000004400 serine Nutrition 0.000 claims description 19
• 235000013922 glutamic acid Nutrition 0.000 claims description 18
• 239000004220 glutamic acid Substances 0.000 claims description 18
• KJBQDYDTQCIAFO-ZLELNMGESA-N (2s)-2-amino-4-methylpentanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound CC(C)C[C@H](N)C(O)=O.NCCCC[C@H](N)C(O)=O KJBQDYDTQCIAFO-ZLELNMGESA-N 0.000 claims description 17
• 229910052799 carbon Inorganic materials 0.000 claims description 14
• 208000011580 syndromic disease Diseases 0.000 claims description 14
• 206010061762 Chondropathy Diseases 0.000 claims description 13
• 239000004471 Glycine Substances 0.000 claims description 13
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 12
• 230000002378 acidificating effect Effects 0.000 claims description 11
• 108090000625 Cathepsin K Proteins 0.000 claims description 9
• 102000004171 Cathepsin K Human genes 0.000 claims description 9
• 229910052739 hydrogen Inorganic materials 0.000 claims description 9
• SEFLNGWGXSFZMH-DQZFIDPSSA-N (2s)-2-aminobutanedioic acid;(2s,3s)-2-amino-3-methylpentanoic acid Chemical compound CC[C@H](C)[C@H](N)C(O)=O.OC(=O)[C@@H](N)CC(O)=O SEFLNGWGXSFZMH-DQZFIDPSSA-N 0.000 claims description 7
• 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 claims description 7
• 150000002333 glycines Chemical class 0.000 claims description 6
• 229910052721 tungsten Inorganic materials 0.000 claims description 6
• 229920000805 Polyaspartic acid Polymers 0.000 claims description 5
• 108010020346 Polyglutamic Acid Proteins 0.000 claims description 5
• 108010064470 polyaspartate Proteins 0.000 claims description 5
• 229920002643 polyglutamic acid Polymers 0.000 claims description 5
• 102000002451 NPR2 Human genes 0.000 claims 24
• 150000003355 serines Chemical class 0.000 claims 2
• 208000035475 disorder Diseases 0.000 abstract description 52
• 150000007523 nucleic acids Chemical class 0.000 abstract description 48
• 102000039446 nucleic acids Human genes 0.000 abstract description 38
• 108020004707 nucleic acids Proteins 0.000 abstract description 38
• 206010008723 Chondrodystrophy Diseases 0.000 abstract description 30
• 208000008919 achondroplasia Diseases 0.000 abstract description 27
• 238000011282 treatment Methods 0.000 abstract description 19
• 108010076504 Protein Sorting Signals Proteins 0.000 description 291
• 125000005647 linker group Chemical group 0.000 description 100
• 102000012421 C-Type Natriuretic Peptide Human genes 0.000 description 92
• 101800000060 C-type natriuretic peptide Proteins 0.000 description 92
• 230000009984 peri-natal effect Effects 0.000 description 89
• 101800002899 Soluble alkaline phosphatase Proteins 0.000 description 86
• -1 e.g. Chemical group 0.000 description 77
• 101000574445 Homo sapiens Alkaline phosphatase, tissue-nonspecific isozyme Proteins 0.000 description 69
• 102100025683 Alkaline phosphatase, tissue-nonspecific isozyme Human genes 0.000 description 67
• XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 65
• 230000035772 mutation Effects 0.000 description 58
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 55
• 230000004927 fusion Effects 0.000 description 50
• 102100039341 Atrial natriuretic peptide receptor 2 Human genes 0.000 description 48
• 241000699670 Mus sp. Species 0.000 description 36
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 33
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 32
• 230000003442 weekly effect Effects 0.000 description 30
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 29
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 28
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 28
• 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 28
• 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 28
• 206010049933 Hypophosphatasia Diseases 0.000 description 26
• 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 26
• 210000004027 cell Anatomy 0.000 description 26
• 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 26
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 25
• 208000009905 Neurofibromatoses Diseases 0.000 description 25
• 201000004931 neurofibromatosis Diseases 0.000 description 25
• 230000000694 effects Effects 0.000 description 23
• 230000001717 pathogenic effect Effects 0.000 description 22
• 108091035707 Consensus sequence Proteins 0.000 description 21
• 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 description 21
• 125000003607 serino group Chemical class [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 21
• 101100180983 Mus musculus Khdrbs3 gene Proteins 0.000 description 20
• 241001415513 Salpida Species 0.000 description 20
• ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 19
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 19
• 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 18
• 238000012217 deletion Methods 0.000 description 18
• 230000037430 deletion Effects 0.000 description 18
• 108090000623 proteins and genes Proteins 0.000 description 18
• 206010072610 Skeletal dysplasia Diseases 0.000 description 17
• 108020001507 fusion proteins Proteins 0.000 description 17
• 102000037865 fusion proteins Human genes 0.000 description 17
• 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 17
• XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 16
• 235000011180 diphosphates Nutrition 0.000 description 16
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 15
• 231100000221 frame shift mutation induction Toxicity 0.000 description 15
• 230000037433 frameshift Effects 0.000 description 15
• 230000001965 increasing effect Effects 0.000 description 15
• 238000006467 substitution reaction Methods 0.000 description 15
• 230000001225 therapeutic effect Effects 0.000 description 15
• 230000005856 abnormality Effects 0.000 description 14
• 229930004094 glycosylphosphatidylinositol Natural products 0.000 description 14
• 238000001727 in vivo Methods 0.000 description 14
• 239000012528 membrane Substances 0.000 description 14
• 235000018102 proteins Nutrition 0.000 description 14
• 102000004169 proteins and genes Human genes 0.000 description 14
• 206010028980 Neoplasm Diseases 0.000 description 13
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 13
• 108010038640 atrial natriuretic factor receptor A Proteins 0.000 description 13
• 102100039339 Atrial natriuretic peptide receptor 1 Human genes 0.000 description 12
• 108091028043 Nucleic acid sequence Proteins 0.000 description 12
• 230000006870 function Effects 0.000 description 12
• 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 12
• 101001128963 Homo sapiens Protein Dr1 Proteins 0.000 description 11
• 102100031227 Protein Dr1 Human genes 0.000 description 11
• 230000002411 adverse Effects 0.000 description 11
• 239000001509 sodium citrate Substances 0.000 description 11
• HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 11
• 229940038773 trisodium citrate Drugs 0.000 description 11
• 102000004190 Enzymes Human genes 0.000 description 10
• 108090000790 Enzymes Proteins 0.000 description 10
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 10
• 208000024834 Neurofibromatosis type 1 Diseases 0.000 description 10
• 108010085793 Neurofibromin 1 Proteins 0.000 description 10
• 235000018417 cysteine Nutrition 0.000 description 10
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 10
• 230000007423 decrease Effects 0.000 description 10
• 229940088598 enzyme Drugs 0.000 description 10
• 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 10
• 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 10
• 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 10
• 206010058314 Dysplasia Diseases 0.000 description 9
• 108010044467 Isoenzymes Proteins 0.000 description 9
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 9
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 9
• 125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 9
• 108091006629 SLC13A2 Proteins 0.000 description 9
• 238000007792 addition Methods 0.000 description 9
• 235000004279 alanine Nutrition 0.000 description 9
• 238000003556 assay Methods 0.000 description 9
• 230000008901 benefit Effects 0.000 description 9
• 230000018678 bone mineralization Effects 0.000 description 9
• 239000000539 dimer Substances 0.000 description 9
• 229910052698 phosphorus Inorganic materials 0.000 description 9
• 229910052727 yttrium Inorganic materials 0.000 description 9
• 102000003729 Neprilysin Human genes 0.000 description 8
• 108090000028 Neprilysin Proteins 0.000 description 8
• 102000007530 Neurofibromin 1 Human genes 0.000 description 8
• 208000020221 Short stature Diseases 0.000 description 8
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 8
• 210000004271 bone marrow stromal cell Anatomy 0.000 description 8
• 239000003795 chemical substances by application Substances 0.000 description 8
• WHUUTDBJXJRKMK-VKHMYHEASA-L glutamate group Chemical group N[C@@H](CCC(=O)[O-])C(=O)[O-] WHUUTDBJXJRKMK-VKHMYHEASA-L 0.000 description 8
• 238000009396 hybridization Methods 0.000 description 8
• 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 8
• 238000002887 multiple sequence alignment Methods 0.000 description 8
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 7
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 7
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 7
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
• 150000001875 compounds Chemical class 0.000 description 7
• 231100000673 dose–response relationship Toxicity 0.000 description 7
• 230000014509 gene expression Effects 0.000 description 7
• 125000000741 isoleucyl group Chemical group [H]N([H])C(C(C([H])([H])[H])C([H])([H])C([H])([H])[H])C(=O)O* 0.000 description 7
• 230000004048 modification Effects 0.000 description 7
• 238000012986 modification Methods 0.000 description 7
• 125000003729 nucleotide group Chemical group 0.000 description 7
• 230000001575 pathological effect Effects 0.000 description 7
• 230000037361 pathway Effects 0.000 description 7
• 230000002829 reductive effect Effects 0.000 description 7
• 239000004474 valine Substances 0.000 description 7
• 239000003981 vehicle Substances 0.000 description 7
• ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 description 6
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
• 241000283690 Bos taurus Species 0.000 description 6
• 208000009283 Craniosynostoses Diseases 0.000 description 6
• 206010049889 Craniosynostosis Diseases 0.000 description 6
• 108020004485 Nonsense Codon Proteins 0.000 description 6
• 206010029748 Noonan syndrome Diseases 0.000 description 6
• SUHOOTKUPISOBE-UHFFFAOYSA-N O-phosphoethanolamine Chemical compound NCCOP(O)(O)=O SUHOOTKUPISOBE-UHFFFAOYSA-N 0.000 description 6
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 6
• 239000004473 Threonine Substances 0.000 description 6
• 230000033558 biomineral tissue development Effects 0.000 description 6
• 210000001612 chondrocyte Anatomy 0.000 description 6
• ZOOGRGPOEVQQDX-UHFFFAOYSA-N cyclic GMP Natural products O1C2COP(O)(=O)OC2C(O)C1N1C=NC2=C1NC(N)=NC2=O ZOOGRGPOEVQQDX-UHFFFAOYSA-N 0.000 description 6
• 230000003247 decreasing effect Effects 0.000 description 6
• 230000012010 growth Effects 0.000 description 6
• 230000037434 nonsense mutation Effects 0.000 description 6
• NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 6
• 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 6
• 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 6
• 150000003839 salts Chemical class 0.000 description 6
• 208000024891 symptom Diseases 0.000 description 6
• 210000002303 tibia Anatomy 0.000 description 6
• 239000013598 vector Substances 0.000 description 6
• 238000005406 washing Methods 0.000 description 6
• WMSPZRZYIGOEDS-QMMMGPOBSA-N 4-[[(1s)-5-amino-1-carboxypentyl]amino]-3,5-dinitrobenzoic acid Chemical compound NCCCC[C@@H](C(O)=O)NC1=C([N+]([O-])=O)C=C(C(O)=O)C=C1[N+]([O-])=O WMSPZRZYIGOEDS-QMMMGPOBSA-N 0.000 description 5
• 108020004414 DNA Proteins 0.000 description 5
• 108010016626 Dipeptides Proteins 0.000 description 5
• 206010013883 Dwarfism Diseases 0.000 description 5
• 241000282326 Felis catus Species 0.000 description 5
• 102100021496 Insulin-degrading enzyme Human genes 0.000 description 5
• 108090000828 Insulysin Proteins 0.000 description 5
• 102000043136 MAP kinase family Human genes 0.000 description 5
• 108091054455 MAP kinase family Proteins 0.000 description 5
• 102100024193 Mitogen-activated protein kinase 1 Human genes 0.000 description 5
• 241000699666 Mus <mouse, genus> Species 0.000 description 5
• 230000002159 abnormal effect Effects 0.000 description 5
• 210000004369 blood Anatomy 0.000 description 5
• 239000008280 blood Substances 0.000 description 5
• 201000011510 cancer Diseases 0.000 description 5
• 210000000845 cartilage Anatomy 0.000 description 5
• 239000013078 crystal Substances 0.000 description 5
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 5
• 229960000310 isoleucine Drugs 0.000 description 5
• 238000004519 manufacturing process Methods 0.000 description 5
• 239000002773 nucleotide Substances 0.000 description 5
• 210000000963 osteoblast Anatomy 0.000 description 5
• 102000016914 ras Proteins Human genes 0.000 description 5
• 239000011780 sodium chloride Substances 0.000 description 5
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 5
• 210000002700 urine Anatomy 0.000 description 5
• 201000010028 Acrocephalosyndactylia Diseases 0.000 description 4
• 102100024321 Alkaline phosphatase, placental type Human genes 0.000 description 4
• 101800001288 Atrial natriuretic factor Proteins 0.000 description 4
• 101800001890 Atrial natriuretic peptide Proteins 0.000 description 4
• 102400001282 Atrial natriuretic peptide Human genes 0.000 description 4
• 102400000667 Brain natriuretic peptide 32 Human genes 0.000 description 4
• 101800000407 Brain natriuretic peptide 32 Proteins 0.000 description 4
• 101800002247 Brain natriuretic peptide 45 Proteins 0.000 description 4
• 102220571886 Cellular tumor antigen p53_A159T_mutation Human genes 0.000 description 4
• DHCLVCXQIBBOPH-UHFFFAOYSA-N Glycerol 2-phosphate Chemical compound OCC(CO)OP(O)(O)=O DHCLVCXQIBBOPH-UHFFFAOYSA-N 0.000 description 4
• 101000615334 Homo sapiens Antileukoproteinase Proteins 0.000 description 4
• 101000961040 Homo sapiens Atrial natriuretic peptide receptor 2 Proteins 0.000 description 4
• 101000897494 Homo sapiens C-C motif chemokine 27 Proteins 0.000 description 4
• 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 4
• 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 4
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 4
• 208000005101 LEOPARD Syndrome Diseases 0.000 description 4
• 239000004472 Lysine Substances 0.000 description 4
• 241000124008 Mammalia Species 0.000 description 4
• 201000004404 Neurofibroma Diseases 0.000 description 4
• 208000010708 Noonan syndrome with multiple lentigines Diseases 0.000 description 4
• 206010031243 Osteogenesis imperfecta Diseases 0.000 description 4
• 101710118538 Protease Proteins 0.000 description 4
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 4
• 208000004064 acoustic neuroma Diseases 0.000 description 4
• HFVAFDPGUJEFBQ-UHFFFAOYSA-M alizarin red S Chemical compound [Na+].O=C1C2=CC=CC=C2C(=O)C2=C1C=C(S([O-])(=O)=O)C(O)=C2O HFVAFDPGUJEFBQ-UHFFFAOYSA-M 0.000 description 4
• 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 4
• 102220351004 c.68C>T Human genes 0.000 description 4
• NSQLIUXCMFBZME-MPVJKSABSA-N carperitide Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 NSQLIUXCMFBZME-MPVJKSABSA-N 0.000 description 4
• 230000015556 catabolic process Effects 0.000 description 4
• 230000008859 change Effects 0.000 description 4
• 208000001020 chondrodysplasia punctata Diseases 0.000 description 4
• 230000007812 deficiency Effects 0.000 description 4
• 238000006731 degradation reaction Methods 0.000 description 4
• 230000008021 deposition Effects 0.000 description 4
• 230000013595 glycosylation Effects 0.000 description 4
• 238000006206 glycosylation reaction Methods 0.000 description 4
• 108010001064 glycyl-glycyl-glycyl-glycine Proteins 0.000 description 4
• 230000000004 hemodynamic effect Effects 0.000 description 4
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 4
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 4
• 230000003902 lesion Effects 0.000 description 4
• 201000010828 metaphyseal dysplasia Diseases 0.000 description 4
• 229930182817 methionine Natural products 0.000 description 4
• HPNRHPKXQZSDFX-OAQDCNSJSA-N nesiritide Chemical compound C([C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 HPNRHPKXQZSDFX-OAQDCNSJSA-N 0.000 description 4
• 108010031345 placental alkaline phosphatase Proteins 0.000 description 4
• 230000004481 post-translational protein modification Effects 0.000 description 4
• 102220277691 rs587781972 Human genes 0.000 description 4
• 102220278926 rs759871071 Human genes 0.000 description 4
• 230000019491 signal transduction Effects 0.000 description 4
• 230000011664 signaling Effects 0.000 description 4
• 210000003625 skull Anatomy 0.000 description 4
• 201000003896 thanatophoric dysplasia Diseases 0.000 description 4
• RGCKGOZRHPZPFP-UHFFFAOYSA-N Alizarin Natural products C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 3
• 102100025677 Alkaline phosphatase, germ cell type Human genes 0.000 description 3
• 239000004475 Arginine Substances 0.000 description 3
• 206010006002 Bone pain Diseases 0.000 description 3
• 208000017501 CBL-related disease Diseases 0.000 description 3
• 108091026890 Coding region Proteins 0.000 description 3
• 201000001200 Crouzon syndrome-acanthosis nigricans syndrome Diseases 0.000 description 3
• 101000574440 Homo sapiens Alkaline phosphatase, germ cell type Proteins 0.000 description 3
• 102100024319 Intestinal-type alkaline phosphatase Human genes 0.000 description 3
• 101710184243 Intestinal-type alkaline phosphatase Proteins 0.000 description 3
• 208000007326 Muenke Syndrome Diseases 0.000 description 3
• 208000034578 Multiple myelomas Diseases 0.000 description 3
• 208000037538 Myelomonocytic Juvenile Leukemia Diseases 0.000 description 3
• 208000033633 Noonan syndrome-like disorder with juvenile myelomonocytic leukemia Diseases 0.000 description 3
• 208000024345 Noonan syndrome-like disorder with loose anagen hair Diseases 0.000 description 3
• 229910019142 PO4 Inorganic materials 0.000 description 3
• 206010035226 Plasma cell myeloma Diseases 0.000 description 3
• 239000004365 Protease Substances 0.000 description 3
• 208000002607 Pseudarthrosis Diseases 0.000 description 3
• 208000006938 Schwannomatosis Diseases 0.000 description 3
• 241000282898 Sus scrofa Species 0.000 description 3
• 208000005065 achondrogenesis Diseases 0.000 description 3
• 201000007047 acrodysostosis Diseases 0.000 description 3
• 208000001884 acromesomelic dysplasia Diseases 0.000 description 3
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
• 201000007845 atelosteogenesis Diseases 0.000 description 3
• 230000036772 blood pressure Effects 0.000 description 3
• 210000002805 bone matrix Anatomy 0.000 description 3
• 102220371037 c.5G>A Human genes 0.000 description 3
• 201000005973 campomelic dysplasia Diseases 0.000 description 3
• 230000003197 catalytic effect Effects 0.000 description 3
• 210000000038 chest Anatomy 0.000 description 3
• 238000010367 cloning Methods 0.000 description 3
• 230000007547 defect Effects 0.000 description 3
• 238000010586 diagram Methods 0.000 description 3
• 238000003182 dose-response assay Methods 0.000 description 3
• 201000010103 fibrous dysplasia Diseases 0.000 description 3
• 201000010072 hypochondroplasia Diseases 0.000 description 3
• 230000000968 intestinal effect Effects 0.000 description 3
• 229910052742 iron Inorganic materials 0.000 description 3
• 238000005304 joining Methods 0.000 description 3
• 201000005992 juvenile myelomonocytic leukemia Diseases 0.000 description 3
• 210000003734 kidney Anatomy 0.000 description 3
• 231100000518 lethal Toxicity 0.000 description 3
• 230000001665 lethal effect Effects 0.000 description 3
• 238000010369 molecular cloning Methods 0.000 description 3
• 239000000178 monomer Substances 0.000 description 3
• 201000009494 neurilemmomatosis Diseases 0.000 description 3
• 208000005368 osteomalacia Diseases 0.000 description 3
• 238000002732 pharmacokinetic assay Methods 0.000 description 3
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
• 239000010452 phosphate Substances 0.000 description 3
• 239000013612 plasmid Substances 0.000 description 3
• 208000003580 polydactyly Diseases 0.000 description 3
• 230000002028 premature Effects 0.000 description 3
• 238000000746 purification Methods 0.000 description 3
• 210000000614 rib Anatomy 0.000 description 3
• 102220193382 rs1057517391 Human genes 0.000 description 3
• 102220234840 rs1131690942 Human genes 0.000 description 3
• 102220198133 rs121913385 Human genes 0.000 description 3
• 102220041065 rs200979664 Human genes 0.000 description 3
• 102200105905 rs375275361 Human genes 0.000 description 3
• 102220193091 rs758723288 Human genes 0.000 description 3
• 102220083084 rs863224616 Human genes 0.000 description 3
• 238000002864 sequence alignment Methods 0.000 description 3
• 241000894007 species Species 0.000 description 3
• 238000010186 staining Methods 0.000 description 3
• 230000002195 synergetic effect Effects 0.000 description 3
• 238000011287 therapeutic dose Methods 0.000 description 3
• 210000000689 upper leg Anatomy 0.000 description 3
• 238000001262 western blot Methods 0.000 description 3
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
• HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 2
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
• 102220581635 Actin, cytoplasmic 1_M45L_mutation Human genes 0.000 description 2
• 108010011170 Ala-Trp-Arg-His-Pro-Gln-Phe-Gly-Gly Proteins 0.000 description 2
• 208000028060 Albright disease Diseases 0.000 description 2
• 208000025490 Apert syndrome Diseases 0.000 description 2
• 206010002961 Aplasia Diseases 0.000 description 2
• 206010003594 Ataxia telangiectasia Diseases 0.000 description 2
• 102100034605 Atrial natriuretic peptide receptor 3 Human genes 0.000 description 2
• 208000000659 Autoimmune lymphoproliferative syndrome Diseases 0.000 description 2
• 206010062804 Basal cell naevus syndrome Diseases 0.000 description 2
• 206010005003 Bladder cancer Diseases 0.000 description 2
• 201000004940 Bloch-Sulzberger syndrome Diseases 0.000 description 2
• 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 2
• 102000008143 Bone Morphogenetic Protein 2 Human genes 0.000 description 2
• 206010006187 Breast cancer Diseases 0.000 description 2
• 208000026310 Breast neoplasm Diseases 0.000 description 2
• 201000002927 Cardiofaciocutaneous syndrome Diseases 0.000 description 2
• 102220597378 Cellular tumor antigen p53_E294K_mutation Human genes 0.000 description 2
• 201000000304 Cleidocranial dysplasia Diseases 0.000 description 2
• 206010010904 Convulsion Diseases 0.000 description 2
• 206010067380 Costello Syndrome Diseases 0.000 description 2
• 206010066946 Craniofacial dysostosis Diseases 0.000 description 2
• 201000006526 Crouzon syndrome Diseases 0.000 description 2
• ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
• 206010011878 Deafness Diseases 0.000 description 2
• 206010012559 Developmental delay Diseases 0.000 description 2
• 208000000088 Enchondromatosis Diseases 0.000 description 2
• 102220480336 Enoyl-CoA hydratase, mitochondrial_R54H_mutation Human genes 0.000 description 2
• 208000031213 Epidermal nevus syndrome Diseases 0.000 description 2
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
• 206010015995 Eyelid ptosis Diseases 0.000 description 2
• 208000016264 Femoral agenesis/hypoplasia Diseases 0.000 description 2
• 102000018898 GTPase-Activating Proteins Human genes 0.000 description 2
• 108091006094 GTPase-accelerating proteins Proteins 0.000 description 2
• 206010051066 Gastrointestinal stromal tumour Diseases 0.000 description 2
• 208000006334 Gingival Fibromatosis Diseases 0.000 description 2
• 229930186217 Glycolipid Natural products 0.000 description 2
• 208000031995 Gorlin syndrome Diseases 0.000 description 2
• 206010053759 Growth retardation Diseases 0.000 description 2
• 208000030839 Hereditary gingival fibromatosis Diseases 0.000 description 2
• 101000924488 Homo sapiens Atrial natriuretic peptide receptor 3 Proteins 0.000 description 2
• 208000007031 Incontinentia pigmenti Diseases 0.000 description 2
• 208000010809 Ito hypomelanosis Diseases 0.000 description 2
• 208000009289 Jackson-Weiss syndrome Diseases 0.000 description 2
• 208000001182 Kniest dysplasia Diseases 0.000 description 2
• 229930182816 L-glutamine Natural products 0.000 description 2
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical group CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
• LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 2
• 208000008063 Langer mesomelic dysplasia Diseases 0.000 description 2
• 208000006286 Legius syndrome Diseases 0.000 description 2
• 208000006824 Lichtenstein syndrome Diseases 0.000 description 2
• 206010024503 Limb reduction defect Diseases 0.000 description 2
• 206010025323 Lymphomas Diseases 0.000 description 2
• 229940124647 MEK inhibitor Drugs 0.000 description 2
• 208000001826 Marfan syndrome Diseases 0.000 description 2
• 201000001853 McCune-Albright syndrome Diseases 0.000 description 2
• 208000011262 Micromelia Diseases 0.000 description 2
• 206010028095 Mucopolysaccharidosis IV Diseases 0.000 description 2
• 208000003452 Multiple Hereditary Exostoses Diseases 0.000 description 2
• 206010062901 Multiple lentigines syndrome Diseases 0.000 description 2
• 208000010428 Muscle Weakness Diseases 0.000 description 2
• 206010028372 Muscular weakness Diseases 0.000 description 2
• 208000012902 Nervous system disease Diseases 0.000 description 2
• 101150083321 Nf1 gene Proteins 0.000 description 2
• 208000032158 Nievergelt type mesomelic dwarfism Diseases 0.000 description 2
• 208000001697 Odontohypophosphatasia Diseases 0.000 description 2
• 208000004286 Osteochondrodysplasias Diseases 0.000 description 2
• 108090000526 Papain Proteins 0.000 description 2
• 241000009328 Perro Species 0.000 description 2
• 201000004014 Pfeiffer syndrome Diseases 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
• 206010060862 Prostate cancer Diseases 0.000 description 2
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 2
• 208000033787 Rare developmental defect during embryogenesis Diseases 0.000 description 2
• 241000700159 Rattus Species 0.000 description 2
• 208000001647 Renal Insufficiency Diseases 0.000 description 2
• 201000001718 Roberts syndrome Diseases 0.000 description 2
• 208000005568 Robinow syndrome Diseases 0.000 description 2
• 208000009163 Sebaceous of Jadassohn Nevus Diseases 0.000 description 2
• YIQKLZYTHXTDDT-UHFFFAOYSA-H Sirius red F3B Chemical compound C1=CC(=CC=C1N=NC2=CC(=C(C=C2)N=NC3=C(C=C4C=C(C=CC4=C3[O-])NC(=O)NC5=CC6=CC(=C(C(=C6C=C5)[O-])N=NC7=C(C=C(C=C7)N=NC8=CC=C(C=C8)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] YIQKLZYTHXTDDT-UHFFFAOYSA-H 0.000 description 2
• 206010042265 Sturge-Weber Syndrome Diseases 0.000 description 2
• 206010042778 Syndactyly Diseases 0.000 description 2
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
• 208000026911 Tuberous sclerosis complex Diseases 0.000 description 2
• DVEXZJFMOKTQEZ-JYFOCSDGSA-N U0126 Chemical compound C=1C=CC=C(N)C=1SC(\N)=C(/C#N)\C(\C#N)=C(/N)SC1=CC=CC=C1N DVEXZJFMOKTQEZ-JYFOCSDGSA-N 0.000 description 2
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 2
• 208000014070 Vestibular schwannoma Diseases 0.000 description 2
• 229930003268 Vitamin C Natural products 0.000 description 2
• 208000026724 Waardenburg syndrome Diseases 0.000 description 2
• 102220637237 Zona pellucida sperm-binding protein 1_M45I_mutation Human genes 0.000 description 2
• 238000009825 accumulation Methods 0.000 description 2
• 239000002253 acid Substances 0.000 description 2
• 230000009471 action Effects 0.000 description 2
• 230000004913 activation Effects 0.000 description 2
• 230000004872 arterial blood pressure Effects 0.000 description 2
• 230000002146 bilateral effect Effects 0.000 description 2
• 201000006715 brachydactyly Diseases 0.000 description 2
• 244000309464 bull Species 0.000 description 2
• 102200125602 c.1142A>G Human genes 0.000 description 2
• 102220371021 c.1180A>G Human genes 0.000 description 2
• 102220355249 c.137G>T Human genes 0.000 description 2
• 102220365436 c.295G>T Human genes 0.000 description 2
• 102200127604 c.395C>T Human genes 0.000 description 2
• 102220346343 c.662G>T Human genes 0.000 description 2
• UASRYODFRYWBRC-UHFFFAOYSA-N cGMP Natural products N1C(N)=NC(=O)C2=C1N(C1C3OP(O)(=O)OC3C(CO)O1)C=N2 UASRYODFRYWBRC-UHFFFAOYSA-N 0.000 description 2
• 208000014729 capillary malformation Diseases 0.000 description 2
• 125000004432 carbon atom Chemical group C* 0.000 description 2
• 230000001413 cellular effect Effects 0.000 description 2
• 238000004440 column chromatography Methods 0.000 description 2
• 210000004489 deciduous teeth Anatomy 0.000 description 2
• 210000001750 dental cementum Anatomy 0.000 description 2
• 208000022734 developmental defect during embryogenesis Diseases 0.000 description 2
• 230000004882 diastolic arterial blood pressure Effects 0.000 description 2
• 201000007394 diastrophic dysplasia Diseases 0.000 description 2
• OLSDWRNWUGHKSY-UHFFFAOYSA-J dicalcium;phosphonato phosphate;dihydrate Chemical compound O.O.[Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O OLSDWRNWUGHKSY-UHFFFAOYSA-J 0.000 description 2
• 230000004069 differentiation Effects 0.000 description 2
• 239000003937 drug carrier Substances 0.000 description 2
• 230000002255 enzymatic effect Effects 0.000 description 2
• 210000002744 extracellular matrix Anatomy 0.000 description 2
• 210000003414 extremity Anatomy 0.000 description 2
• 208000009618 familial spinal neurofibromatosis Diseases 0.000 description 2
• 208000003350 fibrochondrogenesis Diseases 0.000 description 2
• 238000009472 formulation Methods 0.000 description 2
• 201000011243 gastrointestinal stromal tumor Diseases 0.000 description 2
• 208000005017 glioblastoma Diseases 0.000 description 2
• 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 description 2
• 210000004349 growth plate Anatomy 0.000 description 2
• 231100000001 growth retardation Toxicity 0.000 description 2
• 208000016354 hearing loss disease Diseases 0.000 description 2
• 201000010928 hereditary multiple exostoses Diseases 0.000 description 2
• 238000004128 high performance liquid chromatography Methods 0.000 description 2
• 208000003906 hydrocephalus Diseases 0.000 description 2
• 230000007062 hydrolysis Effects 0.000 description 2
• 238000006460 hydrolysis reaction Methods 0.000 description 2
• 230000002209 hydrophobic effect Effects 0.000 description 2
• 201000010118 hypomelanosis of Ito Diseases 0.000 description 2
• 208000011111 hypophosphatemic rickets Diseases 0.000 description 2
• 230000001077 hypotensive effect Effects 0.000 description 2
• FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
• 230000006872 improvement Effects 0.000 description 2
• 238000000338 in vitro Methods 0.000 description 2
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
• 230000003834 intracellular effect Effects 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• 201000006370 kidney failure Diseases 0.000 description 2
• 201000003723 learning disability Diseases 0.000 description 2
• 208000032839 leukemia Diseases 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 208000020038 linear nevus sebaceous syndrome Diseases 0.000 description 2
• 210000004185 liver Anatomy 0.000 description 2
• 208000035853 malformation syndrome Diseases 0.000 description 2
• 238000007726 management method Methods 0.000 description 2
• 206010027191 meningioma Diseases 0.000 description 2
• 208000010978 mucopolysaccharidosis type 4 Diseases 0.000 description 2
• 230000002071 myeloproliferative effect Effects 0.000 description 2
• 208000024550 neurocutaneous melanocytosis Diseases 0.000 description 2
• 208000006943 neurofibromatosis-pheochromocytoma-duodenal carcinoid syndrome Diseases 0.000 description 2
• 201000005734 nevoid basal cell carcinoma syndrome Diseases 0.000 description 2
• 229910052757 nitrogen Inorganic materials 0.000 description 2
• 201000008482 osteoarthritis Diseases 0.000 description 2
• 208000002865 osteopetrosis Diseases 0.000 description 2
• 206010031281 osteopoikilosis Diseases 0.000 description 2
• 229940055729 papain Drugs 0.000 description 2
• 235000019834 papain Nutrition 0.000 description 2
• 230000036961 partial effect Effects 0.000 description 2
• 208000027612 peripheral dysostosis Diseases 0.000 description 2
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
• 230000026731 phosphorylation Effects 0.000 description 2
• 238000006366 phosphorylation reaction Methods 0.000 description 2
• 208000031223 plasma cell leukemia Diseases 0.000 description 2
• 208000001061 polyostotic fibrous dysplasia Diseases 0.000 description 2
• 201000003004 ptosis Diseases 0.000 description 2
• 102000005962 receptors Human genes 0.000 description 2
• 108020003175 receptors Proteins 0.000 description 2
• 108010023714 recombinant human bone morphogenetic protein-2 Proteins 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 208000007442 rickets Diseases 0.000 description 2
• 102200125564 rs1054159992 Human genes 0.000 description 2
• 102200127596 rs1057521085 Human genes 0.000 description 2
• 102220223205 rs1060502158 Human genes 0.000 description 2
• 102220234575 rs1114167537 Human genes 0.000 description 2
• 102220335652 rs1188506084 Human genes 0.000 description 2
• 102200127535 rs121918000 Human genes 0.000 description 2
• 102200127580 rs121918001 Human genes 0.000 description 2
• 102200127578 rs121918003 Human genes 0.000 description 2
• 102200127546 rs121918004 Human genes 0.000 description 2
• 102200127443 rs121918005 Human genes 0.000 description 2
• 102200125560 rs121918006 Human genes 0.000 description 2
• 102200127548 rs121918007 Human genes 0.000 description 2
• 102200125608 rs121918009 Human genes 0.000 description 2
• 102200127517 rs121918012 Human genes 0.000 description 2
• 102200127609 rs121918015 Human genes 0.000 description 2
• 102200125567 rs121918016 Human genes 0.000 description 2
• 102200127539 rs121918019 Human genes 0.000 description 2
• 102220004769 rs121918020 Human genes 0.000 description 2
• 102200127376 rs1226800998 Human genes 0.000 description 2
• 102220249183 rs1320839573 Human genes 0.000 description 2
• 102200107820 rs1423803759 Human genes 0.000 description 2
• 102200125527 rs1442918125 Human genes 0.000 description 2
• 102220289416 rs146463120 Human genes 0.000 description 2
• 102220270670 rs1486768673 Human genes 0.000 description 2
• 102200127582 rs1490668038 Human genes 0.000 description 2
• 102220193384 rs149889416 Human genes 0.000 description 2
• 102220276899 rs1553350215 Human genes 0.000 description 2
• 102200125572 rs1553414079 Human genes 0.000 description 2
• 102220335807 rs1553414868 Human genes 0.000 description 2
• 102220317871 rs1554069530 Human genes 0.000 description 2
• 102220282917 rs1555568159 Human genes 0.000 description 2
• 102220282400 rs1555570409 Human genes 0.000 description 2
• 102200127537 rs199590449 Human genes 0.000 description 2
• 102200127541 rs199669988 Human genes 0.000 description 2
• 102220126966 rs200066994 Human genes 0.000 description 2
• 102220298347 rs201415443 Human genes 0.000 description 2
• 102200104567 rs201744589 Human genes 0.000 description 2
• 102220257328 rs267607954 Human genes 0.000 description 2
• 102220331700 rs267608203 Human genes 0.000 description 2
• 102220289580 rs33916541 Human genes 0.000 description 2
• 102220097232 rs376616485 Human genes 0.000 description 2
• 102220319912 rs376770473 Human genes 0.000 description 2
• 102220004767 rs387906525 Human genes 0.000 description 2
• 102200065274 rs387907573 Human genes 0.000 description 2
• 102220310455 rs397516117 Human genes 0.000 description 2
• 102200057450 rs515726129 Human genes 0.000 description 2
• 102220056930 rs534282225 Human genes 0.000 description 2
• 102220207975 rs58272575 Human genes 0.000 description 2
• 102220036464 rs587779835 Human genes 0.000 description 2
• 102220215718 rs750503329 Human genes 0.000 description 2
• 102220277056 rs759501511 Human genes 0.000 description 2
• 102220284313 rs759603316 Human genes 0.000 description 2
• 102200127549 rs763159520 Human genes 0.000 description 2
• 102200127375 rs766076920 Human genes 0.000 description 2
• 102220216875 rs767032884 Human genes 0.000 description 2
• 102220215717 rs767741687 Human genes 0.000 description 2
• 102220124373 rs768555495 Human genes 0.000 description 2
• 102200125522 rs781272386 Human genes 0.000 description 2
• 102220062428 rs786203554 Human genes 0.000 description 2
• 102200125518 rs786204473 Human genes 0.000 description 2
• 102200062514 rs786204929 Human genes 0.000 description 2
• 102200067517 rs80358805 Human genes 0.000 description 2
• 102220089666 rs869312996 Human genes 0.000 description 2
• 102220093818 rs876658372 Human genes 0.000 description 2
• 102220096737 rs876658797 Human genes 0.000 description 2
• 102220102842 rs878854693 Human genes 0.000 description 2
• 102220191132 rs886057152 Human genes 0.000 description 2
• 206010039722 scoliosis Diseases 0.000 description 2
• 230000028327 secretion Effects 0.000 description 2
• 208000005706 short rib-polydactyly syndrome Diseases 0.000 description 2
• 150000003384 small molecules Chemical class 0.000 description 2
• 201000010809 spondyloepimetaphyseal dysplasia Diseases 0.000 description 2
• 201000003504 spondyloepiphyseal dysplasia congenita Diseases 0.000 description 2
• 238000010561 standard procedure Methods 0.000 description 2
• 229910052717 sulfur Inorganic materials 0.000 description 2
• 230000004873 systolic arterial blood pressure Effects 0.000 description 2
• 238000002560 therapeutic procedure Methods 0.000 description 2
• 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 description 2
• 208000009999 tuberous sclerosis Diseases 0.000 description 2
• 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
• 241000701161 unidentified adenovirus Species 0.000 description 2
• 201000005112 urinary bladder cancer Diseases 0.000 description 2
• 235000019154 vitamin C Nutrition 0.000 description 2
• 239000011718 vitamin C Substances 0.000 description 2
• 208000006542 von Hippel-Lindau disease Diseases 0.000 description 2
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
• UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 description 1
• ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
• 206010000349 Acanthosis Diseases 0.000 description 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
• 208000009304 Acute Kidney Injury Diseases 0.000 description 1
• 102220487920 Alkaline phosphatase, tissue-nonspecific isozyme_A51V_mutation Human genes 0.000 description 1
• 102220488963 Alkaline phosphatase, tissue-nonspecific isozyme_D189E_mutation Human genes 0.000 description 1
• 102220488949 Alkaline phosphatase, tissue-nonspecific isozyme_D406G_mutation Human genes 0.000 description 1
• 102220488695 Alkaline phosphatase, tissue-nonspecific isozyme_F327G_mutation Human genes 0.000 description 1
• 102220488927 Alkaline phosphatase, tissue-nonspecific isozyme_G220A_mutation Human genes 0.000 description 1
• 102220488692 Alkaline phosphatase, tissue-nonspecific isozyme_G326R_mutation Human genes 0.000 description 1
• 102220481151 Alkaline phosphatase, tissue-nonspecific isozyme_I490F_mutation Human genes 0.000 description 1
• 102220488703 Alkaline phosphatase, tissue-nonspecific isozyme_L289F_mutation Human genes 0.000 description 1
• 102220480910 Alkaline phosphatase, tissue-nonspecific isozyme_L414M_mutation Human genes 0.000 description 1
• 102220488708 Alkaline phosphatase, tissue-nonspecific isozyme_M295T_mutation Human genes 0.000 description 1
• 102220487922 Alkaline phosphatase, tissue-nonspecific isozyme_M62L_mutation Human genes 0.000 description 1
• 102220487924 Alkaline phosphatase, tissue-nonspecific isozyme_M62V_mutation Human genes 0.000 description 1
• 102220488976 Alkaline phosphatase, tissue-nonspecific isozyme_N170D_mutation Human genes 0.000 description 1
• 102220488966 Alkaline phosphatase, tissue-nonspecific isozyme_N211D_mutation Human genes 0.000 description 1
• 102220481204 Alkaline phosphatase, tissue-nonspecific isozyme_N478I_mutation Human genes 0.000 description 1
• 102220488632 Alkaline phosphatase, tissue-nonspecific isozyme_R246S_mutation Human genes 0.000 description 1
• 102220487510 Alkaline phosphatase, tissue-nonspecific isozyme_S17F_mutation Human genes 0.000 description 1
• 102220487905 Alkaline phosphatase, tissue-nonspecific isozyme_T68M_mutation Human genes 0.000 description 1
• 208000008822 Ankylosis Diseases 0.000 description 1
• 101710170876 Antileukoproteinase Proteins 0.000 description 1
• 206010003210 Arteriosclerosis Diseases 0.000 description 1
• 241000972773 Aulopiformes Species 0.000 description 1
• 208000000412 Avitaminosis Diseases 0.000 description 1
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
• 102100024522 Bladder cancer-associated protein Human genes 0.000 description 1
• 101150110835 Blcap gene Proteins 0.000 description 1
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
• 208000011491 Bowing of the legs Diseases 0.000 description 1
• 206010048409 Brain malformation Diseases 0.000 description 1
• 101710112538 C-C motif chemokine 27 Proteins 0.000 description 1
• 101100067721 Caenorhabditis elegans gly-3 gene Proteins 0.000 description 1
• 101100454807 Caenorhabditis elegans lgg-1 gene Proteins 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 241000282465 Canis Species 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• 208000009447 Cardiac Edema Diseases 0.000 description 1
• 206010007556 Cardiac failure acute Diseases 0.000 description 1
• 206010007559 Cardiac failure congestive Diseases 0.000 description 1
• 208000024172 Cardiovascular disease Diseases 0.000 description 1
• 206010007747 Cataract congenital Diseases 0.000 description 1
• 102220592243 Cellular tumor antigen p53_F328L_mutation Human genes 0.000 description 1
• 206010008252 Cervical cord compression Diseases 0.000 description 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
• 206010009269 Cleft palate Diseases 0.000 description 1
• 108020004705 Codon Proteins 0.000 description 1
• 208000032170 Congenital Abnormalities Diseases 0.000 description 1
• 206010010356 Congenital anomaly Diseases 0.000 description 1
• 241000518994 Conta Species 0.000 description 1
• 108010051219 Cre recombinase Proteins 0.000 description 1
• 102000053602 DNA Human genes 0.000 description 1
• 208000018035 Dental disease Diseases 0.000 description 1
• 102100031480 Dual specificity mitogen-activated protein kinase kinase 1 Human genes 0.000 description 1
• 101710146526 Dual specificity mitogen-activated protein kinase kinase 1 Proteins 0.000 description 1
• 102100023266 Dual specificity mitogen-activated protein kinase kinase 2 Human genes 0.000 description 1
• 101710146529 Dual specificity mitogen-activated protein kinase kinase 2 Proteins 0.000 description 1
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
• 241000283073 Equus caballus Species 0.000 description 1
• 241000588724 Escherichia coli Species 0.000 description 1
• 108700039887 Essential Genes Proteins 0.000 description 1
• 108700024394 Exon Proteins 0.000 description 1
• 241000282324 Felis Species 0.000 description 1
• 206010017076 Fracture Diseases 0.000 description 1
• 206010017577 Gait disturbance Diseases 0.000 description 1
• 208000010300 Genu Varum Diseases 0.000 description 1
• 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
• 108010078321 Guanylate Cyclase Proteins 0.000 description 1
• 102000014469 Guanylate cyclase Human genes 0.000 description 1
• 239000007995 HEPES buffer Substances 0.000 description 1
• 206010019280 Heart failures Diseases 0.000 description 1
• 101000749809 Homo sapiens 2',3'-cyclic-nucleotide 3'-phosphodiesterase Proteins 0.000 description 1
• 101500027325 Homo sapiens Atrial natriuretic peptide Proteins 0.000 description 1
• 101000961044 Homo sapiens Atrial natriuretic peptide receptor 1 Proteins 0.000 description 1
• 101500026735 Homo sapiens Brain natriuretic peptide 32 Proteins 0.000 description 1
• 101000796277 Homo sapiens C-type natriuretic peptide Proteins 0.000 description 1
• 101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 description 1
• 101500027331 Homo sapiens Urodilatin Proteins 0.000 description 1
• 206010020772 Hypertension Diseases 0.000 description 1
• 206010021135 Hypovitaminosis Diseases 0.000 description 1
• UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 1
• 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 1
• 208000026350 Inborn Genetic disease Diseases 0.000 description 1
• 208000011327 Increased bone mineral density Diseases 0.000 description 1
• 102000004877 Insulin Human genes 0.000 description 1
• 108090001061 Insulin Proteins 0.000 description 1
• 206010023198 Joint ankylosis Diseases 0.000 description 1
• 206010062061 Knee deformity Diseases 0.000 description 1
• ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical class OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 1
• 208000035752 Live birth Diseases 0.000 description 1
• 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 1
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
• JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
• 101710113100 Membrane-bound alkaline phosphatase Proteins 0.000 description 1
• 208000036626 Mental retardation Diseases 0.000 description 1
• 241001465754 Metazoa Species 0.000 description 1
• 208000025966 Neurological disease Diseases 0.000 description 1
• 102100021969 Nucleotide pyrophosphatase Human genes 0.000 description 1
• 208000008589 Obesity Diseases 0.000 description 1
• 206010030113 Oedema Diseases 0.000 description 1
• 101100493740 Oryza sativa subsp. japonica BC10 gene Proteins 0.000 description 1
• 208000001132 Osteoporosis Diseases 0.000 description 1
• 208000005141 Otitis Diseases 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
• 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
• 108091000080 Phosphotransferase Proteins 0.000 description 1
• 208000012641 Pigmentation disease Diseases 0.000 description 1
• 206010036172 Porencephaly Diseases 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• 208000033626 Renal failure acute Diseases 0.000 description 1
• 206010062348 Skull malformation Diseases 0.000 description 1
• 108010076818 TEV protease Proteins 0.000 description 1
• 206010044443 Transposition of the great vessels Diseases 0.000 description 1
• 108010028230 Trp-Ser- His-Pro-Gln-Phe-Glu-Lys Proteins 0.000 description 1
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical class O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 1
• 241000700605 Viruses Species 0.000 description 1
• 208000021017 Weight Gain Diseases 0.000 description 1
• PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
• 239000000370 acceptor Substances 0.000 description 1
• 230000021736 acetylation Effects 0.000 description 1
• 238000006640 acetylation reaction Methods 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 125000000217 alkyl group Chemical group 0.000 description 1
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
• 230000009435 amidation Effects 0.000 description 1
• 238000007112 amidation reaction Methods 0.000 description 1
• 238000004873 anchoring Methods 0.000 description 1
• 235000021120 animal protein Nutrition 0.000 description 1
• 208000011775 arteriosclerosis disease Diseases 0.000 description 1
• 125000003118 aryl group Chemical group 0.000 description 1
• 229940072107 ascorbate Drugs 0.000 description 1
• 235000010323 ascorbic acid Nutrition 0.000 description 1
• 239000011668 ascorbic acid Substances 0.000 description 1
• 230000001746 atrial effect Effects 0.000 description 1
• 238000002869 basic local alignment search tool Methods 0.000 description 1
• 239000011324 bead Substances 0.000 description 1
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 230000031018 biological processes and functions Effects 0.000 description 1
• 230000008468 bone growth Effects 0.000 description 1
• 239000000872 buffer Substances 0.000 description 1
• 102220366430 c.1064A>C Human genes 0.000 description 1
• 102220360149 c.1258G>A Human genes 0.000 description 1
• 102220415458 c.1276G>T Human genes 0.000 description 1
• 102220414911 c.1283G>C Human genes 0.000 description 1
• 102220358448 c.1364G>A Human genes 0.000 description 1
• 102220417888 c.152G>T Human genes 0.000 description 1
• 102220429258 c.283G>A Human genes 0.000 description 1
• 102220391064 c.346G>T Human genes 0.000 description 1
• 102220391267 c.394G>A Human genes 0.000 description 1
• 102220357834 c.500C>T Human genes 0.000 description 1
• 102220427130 c.59T>C Human genes 0.000 description 1
• 102220402980 c.971A>G Human genes 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 239000007894 caplet Substances 0.000 description 1
• 239000002775 capsule Substances 0.000 description 1
• 239000000969 carrier Substances 0.000 description 1
• 230000001364 causal effect Effects 0.000 description 1
• 230000024245 cell differentiation Effects 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 210000000170 cell membrane Anatomy 0.000 description 1
• 208000012056 cerebral malformation Diseases 0.000 description 1
• 238000006243 chemical reaction Methods 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 208000020832 chronic kidney disease Diseases 0.000 description 1
• 230000001149 cognitive effect Effects 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 208000028831 congenital heart disease Diseases 0.000 description 1
• 210000000877 corpus callosum Anatomy 0.000 description 1
• 238000012937 correction Methods 0.000 description 1
• 231100000895 deafness Toxicity 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 230000006735 deficit Effects 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 230000018109 developmental process Effects 0.000 description 1
• 239000002934 diuretic Substances 0.000 description 1
• 239000002552 dosage form Substances 0.000 description 1
• 208000019258 ear infection Diseases 0.000 description 1
• 210000005069 ears Anatomy 0.000 description 1
• 230000035194 endochondral ossification Effects 0.000 description 1
• 238000002641 enzyme replacement therapy Methods 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 230000001747 exhibiting effect Effects 0.000 description 1
• 239000013604 expression vector Substances 0.000 description 1
• 230000002349 favourable effect Effects 0.000 description 1
• 239000012091 fetal bovine serum Substances 0.000 description 1
• 210000002082 fibula Anatomy 0.000 description 1
• 210000003811 finger Anatomy 0.000 description 1
• 210000004905 finger nail Anatomy 0.000 description 1
• 210000002683 foot Anatomy 0.000 description 1
• 230000022244 formylation Effects 0.000 description 1
• 238000006170 formylation reaction Methods 0.000 description 1
• UHBYWPGGCSDKFX-VKHMYHEASA-N gamma-carboxy-L-glutamic acid Chemical compound OC(=O)[C@@H](N)CC(C(O)=O)C(O)=O UHBYWPGGCSDKFX-VKHMYHEASA-N 0.000 description 1
• 230000002496 gastric effect Effects 0.000 description 1
• 239000007897 gelcap Substances 0.000 description 1
• 208000016361 genetic disease Diseases 0.000 description 1
• 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
• 210000002288 golgi apparatus Anatomy 0.000 description 1
• 239000003102 growth factor Substances 0.000 description 1
• 210000004247 hand Anatomy 0.000 description 1
• 210000003128 head Anatomy 0.000 description 1
• 231100000888 hearing loss Toxicity 0.000 description 1
• 230000010370 hearing loss Effects 0.000 description 1
• 230000002440 hepatic effect Effects 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 102000045328 human ALPL Human genes 0.000 description 1
• 102000047974 human CNP Human genes 0.000 description 1
• 210000002758 humerus Anatomy 0.000 description 1
• 201000009075 hydranencephaly Diseases 0.000 description 1
• 230000033444 hydroxylation Effects 0.000 description 1
• 238000005805 hydroxylation reaction Methods 0.000 description 1
• 238000003384 imaging method Methods 0.000 description 1
• 229940072221 immunoglobulins Drugs 0.000 description 1
• 238000001114 immunoprecipitation Methods 0.000 description 1
• 230000001771 impaired effect Effects 0.000 description 1
• 230000002779 inactivation Effects 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 230000002401 inhibitory effect Effects 0.000 description 1
• 238000003780 insertion Methods 0.000 description 1
• 230000037431 insertion Effects 0.000 description 1
• 229940125396 insulin Drugs 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• 229940043355 kinase inhibitor Drugs 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 238000004811 liquid chromatography Methods 0.000 description 1
• 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
• 230000004777 loss-of-function mutation Effects 0.000 description 1
• 239000006166 lysate Substances 0.000 description 1
• 239000011777 magnesium Substances 0.000 description 1
• 229910052749 magnesium Inorganic materials 0.000 description 1
• 229910001425 magnesium ion Inorganic materials 0.000 description 1
• 210000004962 mammalian cell Anatomy 0.000 description 1
• 238000005621 mannosylation reaction Methods 0.000 description 1
• 238000004949 mass spectrometry Methods 0.000 description 1
• 108020004999 messenger RNA Proteins 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 229910021645 metal ion Inorganic materials 0.000 description 1
• 210000001872 metatarsal bone Anatomy 0.000 description 1
• 230000011987 methylation Effects 0.000 description 1
• 238000007069 methylation reaction Methods 0.000 description 1
• 238000010603 microCT Methods 0.000 description 1
• 208000001491 myopia Diseases 0.000 description 1
• 230000004379 myopia Effects 0.000 description 1
• JSOQIZDOEIKRLY-UHFFFAOYSA-N n-propylnitrous amide Chemical compound CCCNN=O JSOQIZDOEIKRLY-UHFFFAOYSA-N 0.000 description 1
• 230000001452 natriuretic effect Effects 0.000 description 1
• 239000006225 natural substrate Substances 0.000 description 1
• 210000000944 nerve tissue Anatomy 0.000 description 1
• 210000000653 nervous system Anatomy 0.000 description 1
• 108010067588 nucleotide pyrophosphatase Proteins 0.000 description 1
• 235000020824 obesity Nutrition 0.000 description 1
• 230000006548 oncogenic transformation Effects 0.000 description 1
• 230000003287 optical effect Effects 0.000 description 1
• 210000003463 organelle Anatomy 0.000 description 1
• 239000003960 organic solvent Substances 0.000 description 1
• 230000002188 osteogenic effect Effects 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 238000007254 oxidation reaction Methods 0.000 description 1
• 238000002638 palliative care Methods 0.000 description 1
• 208000003278 patent ductus arteriosus Diseases 0.000 description 1
• 230000006320 pegylation Effects 0.000 description 1
• 150000002994 phenylalanines Chemical class 0.000 description 1
• 102000020233 phosphotransferase Human genes 0.000 description 1
• 239000003757 phosphotransferase inhibitor Substances 0.000 description 1
• 230000035790 physiological processes and functions Effects 0.000 description 1
• 239000002504 physiological saline solution Substances 0.000 description 1
• 230000003169 placental effect Effects 0.000 description 1
• 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
• 102000040430 polynucleotide Human genes 0.000 description 1
• 108091033319 polynucleotide Proteins 0.000 description 1
• 239000002157 polynucleotide Substances 0.000 description 1
• 235000017924 poor diet Nutrition 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 239000000047 product Substances 0.000 description 1
• 230000000750 progressive effect Effects 0.000 description 1
• 230000035755 proliferation Effects 0.000 description 1
• 235000019419 proteases Nutrition 0.000 description 1
• 230000006337 proteolytic cleavage Effects 0.000 description 1
• 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
• 210000002320 radius Anatomy 0.000 description 1
• 238000003259 recombinant expression Methods 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 230000010076 replication Effects 0.000 description 1
• 208000037803 restenosis Diseases 0.000 description 1
• 238000003757 reverse transcription PCR Methods 0.000 description 1
• 102200125565 rs1054159992 Human genes 0.000 description 1
• 102200105394 rs1060501198 Human genes 0.000 description 1
• 102200006121 rs1060501260 Human genes 0.000 description 1
• 102220219262 rs1060501616 Human genes 0.000 description 1
• 102220222403 rs1060502790 Human genes 0.000 description 1
• 102220259662 rs1060503340 Human genes 0.000 description 1
• 102220317024 rs1064793174 Human genes 0.000 description 1
• 102220231906 rs1064797330 Human genes 0.000 description 1
• 102220231992 rs1064797368 Human genes 0.000 description 1
• 102220234530 rs1114167509 Human genes 0.000 description 1
• 102220040632 rs115316501 Human genes 0.000 description 1
• 102220237428 rs1185220863 Human genes 0.000 description 1
• 102200032432 rs121912691 Human genes 0.000 description 1
• 102200125571 rs121918002 Human genes 0.000 description 1
• 102200125593 rs121918010 Human genes 0.000 description 1
• 102200125552 rs121918014 Human genes 0.000 description 1
• 102220262140 rs1351515691 Human genes 0.000 description 1
• 102220094537 rs137854567 Human genes 0.000 description 1
• 102200125493 rs1413274209 Human genes 0.000 description 1
• 102220263384 rs142011077 Human genes 0.000 description 1
• 102220045982 rs142498771 Human genes 0.000 description 1
• 102200045114 rs143793528 Human genes 0.000 description 1
• 102200106254 rs144340710 Human genes 0.000 description 1
• 102200020651 rs145588689 Human genes 0.000 description 1
• 102200125569 rs150799088 Human genes 0.000 description 1
• 102220320017 rs151317339 Human genes 0.000 description 1
• 102220292764 rs151325948 Human genes 0.000 description 1
• 102220153640 rs151328414 Human genes 0.000 description 1
• 102200125607 rs1553414563 Human genes 0.000 description 1
• 102200125561 rs1553415041 Human genes 0.000 description 1
• 102220277950 rs1554079213 Human genes 0.000 description 1
• 102220318224 rs1554079972 Human genes 0.000 description 1
• 102220320376 rs1554297948 Human genes 0.000 description 1
• 102220278742 rs1554303894 Human genes 0.000 description 1
• 102220237800 rs1555162327 Human genes 0.000 description 1
• 102220287708 rs1555515611 Human genes 0.000 description 1
• 102200081956 rs1555532483 Human genes 0.000 description 1
• 102200064260 rs1555729468 Human genes 0.000 description 1
• 102220285906 rs1555913161 Human genes 0.000 description 1
• 102220310911 rs1556004400 Human genes 0.000 description 1
• 102200140663 rs17882252 Human genes 0.000 description 1
• 102220020813 rs1800081 Human genes 0.000 description 1
• 102220032594 rs180177470 Human genes 0.000 description 1
• 102220008750 rs193922210 Human genes 0.000 description 1
• 102220024764 rs199472726 Human genes 0.000 description 1
• 102200038960 rs199472729 Human genes 0.000 description 1
• 102200108949 rs199473568 Human genes 0.000 description 1
• 102220094538 rs200598389 Human genes 0.000 description 1
• 102220155622 rs201400971 Human genes 0.000 description 1
• 102220273120 rs201409613 Human genes 0.000 description 1
• 102200059511 rs281875235 Human genes 0.000 description 1
• 102220005208 rs33995148 Human genes 0.000 description 1
• 102200150425 rs35142681 Human genes 0.000 description 1
• 102200144870 rs36087757 Human genes 0.000 description 1
• 102200010171 rs372813783 Human genes 0.000 description 1
• 102220011707 rs375289386 Human genes 0.000 description 1
• 102220270832 rs375824753 Human genes 0.000 description 1
• 102220307643 rs377368967 Human genes 0.000 description 1
• 102220011805 rs386833400 Human genes 0.000 description 1
• 102200128183 rs397508195 Human genes 0.000 description 1
• 102220020801 rs397508755 Human genes 0.000 description 1
• 102220020866 rs41286292 Human genes 0.000 description 1
• 102220017759 rs45482691 Human genes 0.000 description 1
• 102220139932 rs534054965 Human genes 0.000 description 1
• 102220120119 rs540254057 Human genes 0.000 description 1
• 102200073919 rs555164150 Human genes 0.000 description 1
• 102220020991 rs55720177 Human genes 0.000 description 1
• 102220282626 rs55816927 Human genes 0.000 description 1
• 102220054759 rs55863639 Human genes 0.000 description 1
• 102200102736 rs587780729 Human genes 0.000 description 1
• 102220045139 rs587781858 Human genes 0.000 description 1
• 102220045735 rs587782347 Human genes 0.000 description 1
• 102220046781 rs61748415 Human genes 0.000 description 1
• 102220269242 rs746189091 Human genes 0.000 description 1
• 102220306519 rs749155813 Human genes 0.000 description 1
• 102220004768 rs749544042 Human genes 0.000 description 1
• 102220058925 rs750058876 Human genes 0.000 description 1
• 102220216361 rs751114575 Human genes 0.000 description 1
• 102220096734 rs751789834 Human genes 0.000 description 1
• 102220086942 rs753256800 Human genes 0.000 description 1
• 102220126700 rs754902005 Human genes 0.000 description 1
• 102200112217 rs7551175 Human genes 0.000 description 1
• 102220094448 rs755553895 Human genes 0.000 description 1
• 102220240528 rs766891274 Human genes 0.000 description 1
• 102220101237 rs767946700 Human genes 0.000 description 1
• 102220222910 rs771332058 Human genes 0.000 description 1
• 102200125603 rs771540767 Human genes 0.000 description 1
• 102200148685 rs775563122 Human genes 0.000 description 1
• 102220278906 rs779218232 Human genes 0.000 description 1
• 102220215880 rs779332376 Human genes 0.000 description 1
• 102220062938 rs781264043 Human genes 0.000 description 1
• 102220330902 rs782756052 Human genes 0.000 description 1
• 102220059764 rs786201615 Human genes 0.000 description 1
• 102220061982 rs786202620 Human genes 0.000 description 1
• 102220059351 rs786203723 Human genes 0.000 description 1
• 102220062939 rs786204442 Human genes 0.000 description 1
• 102200127618 rs786204530 Human genes 0.000 description 1
• 102220062940 rs786204634 Human genes 0.000 description 1
• 102220069648 rs794727718 Human genes 0.000 description 1
• 102220194567 rs80356486 Human genes 0.000 description 1
• 102220009460 rs80356964 Human genes 0.000 description 1
• 102220083097 rs863224325 Human genes 0.000 description 1
• 102220097500 rs876658362 Human genes 0.000 description 1
• 102200105795 rs876658468 Human genes 0.000 description 1
• 102220095212 rs876659307 Human genes 0.000 description 1
• 102220229721 rs876660645 Human genes 0.000 description 1
• 102220098031 rs876661369 Human genes 0.000 description 1
• 102220101054 rs878853958 Human genes 0.000 description 1
• 102220105839 rs879254840 Human genes 0.000 description 1
• 102200038259 rs879254849 Human genes 0.000 description 1
• 102220144190 rs886059443 Human genes 0.000 description 1
• 102220149361 rs886059909 Human genes 0.000 description 1
• 102220279123 rs896054565 Human genes 0.000 description 1
• 235000019515 salmon Nutrition 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 239000004017 serum-free culture medium Substances 0.000 description 1
• 235000021309 simple sugar Nutrition 0.000 description 1
• 231100001055 skeletal defect Toxicity 0.000 description 1
• 210000003491 skin Anatomy 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• 239000002904 solvent Substances 0.000 description 1
• 208000005198 spinal stenosis Diseases 0.000 description 1
• 239000007858 starting material Substances 0.000 description 1
• 239000008174 sterile solution Substances 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 239000000126 substance Substances 0.000 description 1
• 230000019635 sulfation Effects 0.000 description 1
• 238000005670 sulfation reaction Methods 0.000 description 1
• 239000013589 supplement Substances 0.000 description 1
• 230000003319 supportive effect Effects 0.000 description 1
• 238000002636 symptomatic treatment Methods 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 230000002194 synthesizing effect Effects 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 239000003826 tablet Substances 0.000 description 1
• 230000008685 targeting Effects 0.000 description 1
• 238000011285 therapeutic regimen Methods 0.000 description 1
• 210000003813 thumb Anatomy 0.000 description 1
• 229940104230 thymidine Drugs 0.000 description 1
• 210000001519 tissue Anatomy 0.000 description 1
• 210000004906 toe nail Anatomy 0.000 description 1
• 238000013518 transcription Methods 0.000 description 1
• 230000035897 transcription Effects 0.000 description 1
• 238000001890 transfection Methods 0.000 description 1
• 238000013519 translation Methods 0.000 description 1
• 230000005945 translocation Effects 0.000 description 1
• 208000014903 transposition of the great arteries Diseases 0.000 description 1
• 230000034512 ubiquitination Effects 0.000 description 1
• 238000010798 ubiquitination Methods 0.000 description 1
• IUCCYQIEZNQWRS-DWWHXVEHSA-N ularitide Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 IUCCYQIEZNQWRS-DWWHXVEHSA-N 0.000 description 1
• 210000000623 ulna Anatomy 0.000 description 1
• 241001515965 unidentified phage Species 0.000 description 1
• 210000004291 uterus Anatomy 0.000 description 1
• 230000002792 vascular Effects 0.000 description 1
• 229930003231 vitamin Natural products 0.000 description 1
• 235000013343 vitamin Nutrition 0.000 description 1
• 239000011782 vitamin Substances 0.000 description 1
• 229940088594 vitamin Drugs 0.000 description 1
• 208000030401 vitamin deficiency disease Diseases 0.000 description 1
• 230000004584 weight gain Effects 0.000 description 1
• 235000019786 weight gain Nutrition 0.000 description 1